Preoperative Application Of Buprenorphine(Analgesic) Patch In Orthopedic Surgeries For Postoperative Pain Relief

A Comparative Study to Evaluate Effect Of Preoperative Transdermal Buprenorphine Patch In Orthopedic Surgeries. - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070616

Enrollment

Registered

2024-07-15

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: O- Medical and Surgical Health Condition 3: O- Medical and Surgical

Interventions

Intervention1: buprenorphine patch: Dose-buprenorphine patch(10ug/hr) Route-Transdermal Duration-72hr postoperatively Control Intervention1: buprenorphine patch: buprenorphine patch application Contr

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA status 1,2 patient undergoing replacement surgeries 2.age group 20 to 70 years.

Exclusion criteria

Exclusion criteria: 1.ASA Status 3,4 2.Patient with coagulopathy 3.patient with allergy to test drug/local anaesthetic 4.patient refusal

Design outcomes

Primary

Measure	Time frame
To compare Efficacy of Transdermal Buprenorphine Patch when Applied 12hr and 24hr before surgeryTimepoint: To compare Efficacy of Transdermal Buprenorphine Patch when Applied 12hr and 24hr before surgery	—

Secondary

Measure	Time frame
any side effect assessmentTimepoint: Preoperatively & postoperatively at 1,2,3,4,5,6,12,18,24,36,48,72hr post operatively	—

Countries

India

Contacts

Public ContactDr Yash Patel

GCS Medical College Hospital and Research Centre

divya.kheskani@gmail.com8866884734

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026